AKT1 and acute myeloid leukemia: Biological studies showed that the dysregulation of the PI3K-Akt signaling pathway in AML may cause the activation of downstream signal molecules, regulate tumor cell proliferation, apoptosis processes, and mediate tumor cell resistance to radiotherapy and chemotherapy [47, 48].